Pubs | UCSF School of Medicine Department of Dermatology

Lack of coverage for first-line treatments of pigmentary disorders in contrast to treatments of acne and rosacea: A survey of public and private insurers in California.

Tilahun M, Lester JC PMID: 37068661

Link between obesity and atopic dermatitis: Does obesity predispose to atopic dermatitis, or vice versa?

Yang S, Zhu T, Wakefield JS, Mauro TM, Elias PM, Man MQ PMID: 37029451

National Psoriasis Foundation Telemedicine Task Force guidance for management of psoriatic disease via telemedicine.

Pelet Del Toro N, Yahia R, Feldman SR, Van Voorhees A, Green L, Schwartzman S, Siegel E, Cordoro KM, Desai SR, Kircik L, Liao W, Hawkes JE, Weinberg J, Koo J, Wallace EB, Howard LM, Armstrong A, Han G PMID: 37274387

National Psoriasis Foundation Telemedicine Task Force guidance for management of psoriatic disease via telemedicine.

Quantification methods comparing in vitro and in vivo percutaneous permeation by microneedles and passive diffusion.

Iapichino M, Maibach H, Stoeber B PMID: 37015294

Mpox-A Rapidly Evolving Disease.

Cowen EW, Tkaczyk ER, Norton SA, Leslie KS PMID: 36757705

The Social Determinants of Health and Their Impact on Dermatologic Health, Part 1: The Social Determinants of Health and Their Dermatologic Implications.

Bowers S, Chang AY PMID: 36933920

Do Atopic Dermatitis Patient-Reported Outcomes Correlate With Validated Investigator Global Assessment? Insights From TARGET-AD Registry.

Guttman-Yassky E, Bar J, Rothenberg-Lausell C, Eichenfield L, Grada A, Abuabara K, Chapman M, Calimlim B, Wegzyn C, Gamelli A, Krueger W, Munoz B, Knapp K, Faller R, Crawford J, Silverberg J PMID: 37026893

Brodalumab: 4-Year US Pharmacovigilance Report.

Lebwohl M, Koo J, Leonardi C, Armstrong A, Rawnsley N, Goehring E, Jacobson A PMID: 37026879